113 HR 5748 IH: The Medicaid Generic Drug Price Fairness Act of 2014 U.S. House of Representatives 2014-11-20 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I 113th CONGRESS 2d Session H. R. 5748 IN THE HOUSE OF REPRESENTATIVES November 20, 2014 Mr. Cummings introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To extend the requirement that drug manufacturers that increase prices faster than inflation pay an additional rebate to State Medicaid programs to include manufacturers of generic drugs.

1.

Short title

This Act may be cited as the The Medicaid Generic Drug Price Fairness Act of 2014.

2.

Applying the medicaid additional rebate requirement to manufacturers of generic drugs

(a)

In general

Section 1927(c)(3)(A) of the Social Security Act (42 U.S.C. 1396r–8(c)(3)(A)) is amended— (1)in clause (ii), by striking the period and inserting ,; and (2)by adding at the end the following flush text: and shall be increased by an amount determined in the same manner as the increase in the amount of a rebate for a single source drug or an innovator multiple source drug is determined under paragraph (2).. (b)

Effective date

The amendments made by this section shall apply to rebate periods beginning on or after the date of enactment of this Act.